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Abstract
Background:  When proteins are subjected to proteolytic digestion and analyzed by mass
spectrometry using a method such as 2D LC MS/MS, only a portion of the proteotypic peptides
associated with each protein will be observed. The ability to predict which peptides can and cannot
potentially be observed for a particular experimental dataset has several important applications in
proteomics research including calculation of peptide coverage in terms of potentially detectable
peptides, systems biology analysis of data sets, and protein quantification.
Results: We have developed a methodology for constructing artificial neural networks that can be
used to predict which peptides are potentially observable for a given set of experimental,
instrumental, and analytical conditions for 2D LC MS/MS (a.k.a Multidimensional Protein
Identification Technology [MudPIT]) datasets. Neural network classifiers constructed using this
procedure for two MudPIT datasets exhibit 10-fold cross validation accuracy of about 80%. We
show that a classifier constructed for one dataset has poor predictive performance with the other
dataset, thus demonstrating the need for dataset specific classifiers. Classification results with each
dataset are used to compute informative percent amino acid coverage statistics for each protein in
terms of the predicted detectable peptides in addition to the percent coverage of the complete
sequence. We also demonstrate the utility of predicted peptide observability for systems analysis
to help determine if proteins that were expected but not observed generate sufficient peptides for
detection.
Conclusion: Classifiers that accurately predict the likelihood of detecting proteotypic peptides by
mass spectrometry provide proteomics researchers with powerful new approaches for data
analysis. We demonstrate that the procedure we have developed for building a classifier based on
an individual experimental data set results in classifiers with accuracy comparable to those reported
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in the literature based on large training sets collected from multiple experiments. Our approach
allows the researcher to construct a classifier that is specific for the experimental, instrument, and
analytical conditions of a single experiment and amenable to local, condition-specific,
implementation. The resulting classifiers have application in a number of areas such as
determination of peptide coverage for protein identification, pathway analysis, and protein
quantification.
Background
In high-throughput non-electrophoretic proteomics com-
plex mixtures of proteins are subjected to proteolytic
digestion with an enzyme such as trypsin before the frag-
ments are separated by liquid chromatography (LC) and
analyzed by tandem mass spectrometry. However, for a
particular protein, only a portion of the peptides are actu-
ally observed experimentally and the set of peptides that
are observed from a single protein can vary substantially
from one experiment to another. A number of factors con-
tribute to the inability to detect some peptides and to var-
iations in the peptides that are detected from one
experiment to another. These include incomplete proteo-
lytic digestion, small size, poor binding or elution from
the type of LC column used, the limited mass range that
can be detected by the mass spectrometer, bias toward
detecting peptides with an intense MS signal in mixtures,
the phenomenon of "ion suppression", the charge prior to
ionization, and non-covalent interactions between pep-
tides in the gas phase while in the mass spectrometer [1].
In addition, are substantial differences in the peptides
observed due to variations in the protein extraction and or
solublization methods, tissue types, prefractionation, LC
separation conditions, and differences between gradients
even when the same LC separation conditions are used.
Furthermore, different databases, different search soft-
ware and even different versions of the same software also
influence which peptides that are detected.
We refer to peptides that can be detected as "flyable". The
fact that most proteins in a complex mixture are repre-
sented by only a small number of proteolytic peptides
presents several difficulties for proteomics researchers [2].
These problems include assessment of the level of confi-
dence in protein identifications [3], determining the pep-
tide coverage of proteins [4], determining if "missing"
proteins are potentially observable [5,6], and using pep-
tide observability as an adjustment factor for protein
quantification based on observed peptides [4,7]. Recently
reported methods for predicting peptide observability
have been based on large training datasets from multiple
experiments dealing with a single organism [4,7]. How-
ever, because the observability of peptides depends not
only on the properties of the peptides themselves but also
on specific experimental, instrumental, and analytical
procedures, we contend that it is necessary to provide a
method for predicting peptide observability for a specific
experimental set at the local level. This ability to construct
a classifier for a particular dataset is particularly important
for researchers who work in smaller laboratories, deal
with a variety of organisms and/or tissues, employ a vari-
ety of protein extraction protocols, and/or who use a cen-
tralized facility for proteomics where they have little
control over instrumental and analytical protocols.
Here we describe a method for constructing a classifier for
a proteomics data set that can predict peptide observabil-
ity for a particular set of experimental conditions. We
demonstrate that the classifiers constructed using this
method provide critical information for assessing the
validity of protein identifications and valuable evidence
to support competing hypotheses about the presence or
absence of "missing" proteins in a pathway of interest.
The set of tryptic peptides that are observed under experi-
mental conditions can be divided into two classes – pro-
teotrypic and flyable. Proteotrypic peptides are those
experimentally observable peptides that can be used to
uniquely identify a protein, while flyable peptides are all
peptides that are experimentally observable but may not
be proteotrypic [8]. Proteotypic peptides are a subset of
flyable peptides and flyable peptides are a subset of all
possible tryptic peptides. The spectra generated by mass
spectrometry analysis of a complex peptide mixture are
matched against theoretical spectra generated from an in
silico trypsin-digested protein database. The resulting set
of peptide identifications is then used for protein identifi-
cation. By definition, detection of at least one proteotypic
peptide is required for protein identification.
There is, however, disagreement among researchers about
the number of peptide matches and the peptide coverage
of the protein that are required for an identification to be
considered valid. Protein identifications based on a single
proteotypic peptide (sometimes called "one hit won-
ders") are often viewed with skepticism. Some researchers
contend that a protein identification needs at least two
proteotypic peptides to be valid, while others contend
that a single high quality peptide can be used for identifi-
cation purposes [3]. Furthermore, some proteins produce
only one proteotypic peptide. In addition to the number
of peptides identified, the degree of coverage of the pro-BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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tein by peptides may also be used as a measure to assess
the validity of the identification – this is typically pro-
vided in terms of the percentage of amino acids in the pro-
tein "covered" by identified peptides. However, an
additional and more meaningful statistic is the percentage
of potentially detectable peptides that are observed. This
information has the potential to increase (or decrease) the
credibility of some single proteotypic peptides for identi-
fication and can prevent loss of important data [3] or the
inclusion of erroneous identifications.
Researchers using proteomics are interested in not only
cataloging proteins present, but also in studying the loca-
tion and differential expression of the proteins involved
in biochemical pathways [2]. Often, one or more proteins
referenced to participate in a canonical pathway are not
observed in a proteomics dataset, but most other proteins
in the pathway are present [5,6]. Conversely, a protein
that has never been identified in that pathway may be
identified by a single proteotypic peptide. In the first case,
it is important to know whether these missing proteins
generate a sufficient number of potentially observable
proteotypic peptides to support identification under the
specific experimental conditions or whether the protein
truly appears to be absent. In the second case, it is impor-
tant to determine if a protein may reasonably be expected
to be identified by only one peptide under the experimen-
tal conditions – an identification of a protein with a single
peptide where the protein is predicted to produce many
observable proteotypic peptides should be viewed with
suspicion.
Two recently published papers describe methods for the
prediction of peptide detection using mass spectrometry,
but their methods are distinct from ours. Mallick et al. [4]
have compiled a large training set from multiple yeast
proteomics experiments and built Gaussian mixture dis-
criminant function predictors for a number of different
proteomics platforms. Their goal is to characterize the
general properties of peptides that can be detected using
different proteomics technologies, to determine the cover-
age of the predicted proteome that is detectable using dif-
ferent technologies, and they also argue that their method
can be used to improve protein quantification. Lu et al. [7]
describe a classifier for predicting peptide observability
that is a component of a method for absolute protein
quantification and that adjusts scores for protein abun-
dance based on the predicted detectability of in silico gen-
erated tryptic peptides. In contrast, our procedure is
specifically developed for generating a classifier for a sin-
gle data set to predict flyable peptides for a particular set
of experimental conditions (biological sample, protein
extraction protocol, mass spectrometric instrumentation,
HPLC column type, database search algorithm and set-
tings, etc.) and to be applied locally. We demonstrate that
the resulting classification provides valuable information
with regard to peptide coverage of a protein and can assist
the proteomics researcher in a systems analysis of the
dataset.
Results and discussion
We have developed a procedure for building a classifier to
predict peptide flyability from a proteomics dataset. The
output of the protein identification algorithms for a pro-
teomics dataset includes the proteins that were identified
and the peptides that were used for each protein identifi-
cation. As Figure 1 illustrates, the classifier construction
process includes selection of a set of observed and unob-
served peptides for the training set, extraction of features
to represent the peptides in the training set, normalization
of the feature values, feature subset selection, and training
and testing of the classifier.
Training set compilation strategy
The first step in the process is selection of a set of peptides
for the training data set. The naïve approach is to use all
observed peptides for the positive examples and all non-
observed in silico generated peptides from identified pro-
teins for the negative examples. However, this approach
ignores several complications that arise when processing
proteomics datasets. First, some of the "observed" pep-
tides will be false positive identifications. The probability
that a peptide is a false positive identification is greatly
reduced if it is one of multiple peptides used to identify a
protein since the probability of this occurring by chance is
small [3]. Therefore, we limit the positive examples to the
peptides associated with proteins that were identified
using multiple unique peptides. Peptides chosen for neg-
ative examples are also limited to the set of proteins iden-
tified by multiple peptides. However, selection of negative
examples is also complicated by the fact that the number
peptides observed for a protein is directly related to pro-
tein abundance in the sample. Isotope-free quantification
methods for proteomics datasets make use of the relation-
ship between the number of peptides observed and pro-
tein concentration [9-12]. To avoid the problem of
labeling peptides that were not observed as negative
examples because they are associated with low abundance
proteins, we have chosen to compile the negative exam-
ples from the proteins that were identified with the largest
number of peptides. Although this introduces a bias for
peptides from abundant and large proteins, this strategy
insures, to the extent possible, that the peptides used for
negative examples were present in sufficient quantity to be
potentially observable. We have developed the following
procedure for selection of the training set to ensure that
the peptides selected for the class of observable peptides
are high confidence identifications and that the peptides
selected for the negative examples are truly "unobserva-
ble" under the specific experimental conditions.BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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1. Rank the protein identifications by the number of pep-
tides used in the identification and include only identifi-
cations based at least two distinct peptides.
2. Retrieve the amino acid sequence for each of the pro-
teins in step 1, perform in silico trypsin (or appropriate
enzyme) digestion of the proteins, and compile a list of all
predicted tryptic peptides of length greater than 6 amino
acids (because this number gives a probability of the
sequence identifying another sequence at random of 1 in
196 and which is reasonable for a eukaryote genome of
around 4 billion base-pairs such as human).
Classifier construction process Figure 1
Classifier construction process.BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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3. If a peptide is present in the experimental data, it is
assigned a value of 1 and if it is not observed in the exper-
imental data it is given a value of 0. There will be many
more with a value of 0 than with 1.
4. The peptides labeled with a 1 in the previous step are
used as the positive examples in the training set. Suppose
the size of this set is n. In order assure that peptides used
as negative examples were present in sufficient quantity
for detection and to also help produce a balanced training
set, we select the first n "unobserved" peptides from the
proteins ranked by the number of peptides used for iden-
tification.
Feature generation and classifier construction
Our approach for generating features to represent each
peptide in the training set uses both the features listed in
Table 1 (called Feature Set 1) and features constructed
using properties from the AAIndex [13]. The first set of
features (see Table 1) includes basic properties of the pep-
tide (e.g. mass and size) and features related to the amino
acid composition of the peptide. The AA Index is a compi-
lation in a set of tables of 544 different indices used to
characterize amino acids. It includes indices for wide vari-
ety of characteristics of amino acids including hydropho-
bicity, participation in certain types of structures, etc. A
feature value was generated for each peptide for each
index representing the sum of the index values for all
amino acids in the peptide. Combination of Feature Set 1
and the AAindex features results in a total of 596 features
for each peptide. Although this set includes a large
number of redundant features, we have shown that using
both sets as input for the feature selection process yields
improved classifier performance over use of each feature
set alone. For example, with the avian bursal dataset
described below, the 10-fold classification accuracy of
neural networks built with the AAIndex features only is
72%, with Feature Set 1 only is 71%, and with both fea-
ture sets is 81%. Because the values of the features cover a
wide range of numeric values, NV normalization is used
to make the numeric range of all features 0–1. Feature
subset selection is then performed to find the set of feature
most relevant to the task of predicting flyability and to
remove redundant and non-informative features. We use
a feature selection method that performs a greedy search
through feature space to identify features based on the
level of consistency with class values when the training
data is compared to the entire set of attributes [14]. The
reduced set of features is used to train the classifier. A 3-
layer neural network classifier is constructed with an input
unit for each of the selected features, (i+1)/2 hidden units
where i is the number of input units, and a single output
unit. The neural network is trained using the training set
constructed with the strategy described above and tested
using 10-fold cross validation. Multilayer neural networks
provide a robust method for learning a functional map-
ping from numeric attribute values to a class value – in
this case a mapping from numeric features describing the
peptide to the classes "observable" and "unobservable."
In order to demonstrate the utility of our approach, we
have used the methodology described above to build clas-
sifiers for two different published MudPIT data sets: 1) an
avian bursa of Fabricius data set consisting of 5198 pro-
teins [6], and 2) a Hodgkin's lymphoma model data set
consisting of 3983 proteins [5]. The classifiers built using
our procedure had 10-fold cross validation classification
accuracies of 81% and 72% respectively. Table 2 lists the
features selected that best distinguish observed peptides
from unobservable peptides for both datasets. Table 3
reports the accuracy and confusion matrices for the neural
networks for both data sets based on 10-fold cross valida-
tion.
The features selected tend to be related to structural prop-
erties of the peptides. For example, consider the features
selected for the avian bursa classifier. Prolines tend to
break alpha helices and prolines located adjacent to lysine
Table 1: A list of initial features used for classifier construction in addition to AAIndex features.
Feature Subset 1
Length of peptide
Net charge of peptide
Positive charge
Negative charge
Isoelectric point
Molecular weight
Hydropathicity
Count of each amino acid (20 features)
Percent composition of each amino acid (20 features)
Percent polar amino acids
Percent positive amino acids
Percent negative amino acids
Percent hydrophobic amino acids
A feature selection procedure is used to reduce dimensionality prior to classifier construction.BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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or arginine also interfere with trypsin digestion. Amino
acids with small side chains such as glycine and alanine
increase the flexibility of the peptide. The charge, polarity,
hydrophobicity, and the behavior of the peptide in sol-
vent also influence flyability.
Our classifiers achieved classification accuracies compara-
ble to the rates reported by Mallick et al. [4] and Lu et al.
[7] for much simpler yeast systems. The accuracy statistics
reported by Mallick et al. are difficult to compare to ours
because they report specificity in terms of (1 - positive pre-
dictive ratio) where the positive predictive ratio is defined
as (true positives/(true positives + false positives)) rather
than the more traditional true positive ratio (true posi-
tives/(true positives + false negatives). Lu et al. report a
69% true positive rate for observed and a 90% true posi-
tive rate for non-observed. Note that it is possible to
achieve an 82% true positive rate for the non-observed
class for their classifier by guessing non-observed in every
case. In addition, they include very small peptides (3–5
aa) in their analysis and we exclude peptides of this length
from our study because of the high probability of random
matches to multiple proteins and their lack of power as
unique identifiers.
In order to evaluate the importance of building classifiers
that are specific for a particular dataset, we tested each of
the classifiers above with the data used for training the
other classifier (i.e. avian bursal classifier with Hodgkin's
lymphoma model data set as test set and vice versa). The
results (Table 4) demonstrate that there is a substantial
loss of classifier accuracy when using a classifier trained
with one data set to predict peptide observability with the
other data set. In both cases, the true positive rate (predic-
Table 2: Description of features selected for the classifiers built for the two datasets.
Avian Bursa Dataset
Number of prolines
Percent glycine
Percent alanine
Percent leucine
Percent polar amino acids
Percent hydrophobic amino acids
Percent positive amino acids
Percent negative
Size (Dawson, 1972)
Optimized transfer energy parameter (Oobatake et al., 1985)
Weights for beta-sheet at the window position of 5 (Qian-Sejnowski, 1988)
Transfer free energy from oct to wat (Radzicka-Wolfenden, 1988)
Information measure for C-terminal turn (Robson-Suzuki, 1976)
Amphiphilicity index (Mitaku et al., 2002)
Hodgkin's Lymphoma Model Dataset
Number of cytosienes
Signal sequence helical potential (Argos et al., 1982)
Transer free energy to surface (Bull-Breese, 1974)
Normalized relative frequency of alpha-helix (Isogai et al., 1980)
Normalized relative frequence of double bend (Isogai et al., 1980)
Distance between C-alpha and centroid fo side chain (Levitt, 1976)
Retention coefficient in NAH2PO4 (Meek-Rossetti, 1981)
Interior composition of amino acids intracellular proteins (Fukuchi-Nishikawa, 2001)
Linker propensity from 1-linker dataset (George-Heringa, 2003)
Table 3: 10-fold cross-validation accuracy by class for neural networks generated for two datasets.
Class True positive rate False positive rate Precision Recall ROC Area
Avian Bursal Dataset
Not observed 0.80 0.19 0.81 0.80 0.87
Observed 0.82 0.20 0.80 0.82 0.87
Hodgkin's Lymphoma Model Dataset
Not observed 0.66 0.22 0.75 0.66 0.80
Observed 0.78 0.34 0.70 0.78 0.80BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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tion of observability) decreased dramatically (almost to
the level that would be achieved by random guessing).
These results are consistent with those reported by Mallick
et al. [4] when a classifier trained with yeast data was used
to predict observability with human data. These results
clearly demonstrate the need for classifiers to be trained
for each experimental set.
We use the two classifiers described above for the avian
bursa dataset and the Hodgkin's lymphoma model data-
set to demonstrate the utility of the classifiers for calculat-
ing an informative peptide coverage statistic for proteins
and for analysis of system's biology datasets. In Table 5,
for a subset of proteins that were observed in the data, the
total number of tryptic peptides generated by in silico tryp-
tic digestion, the number observed, the number of pep-
tides predicted to be detectable by each classifier, and the
amino acid coverage both in terms of the total number of
tryptic peptides and in terms of those predicted to be
observable. As expected, in most cases the amino average
coverage for peptides predicted to be detectable is higher,
sometimes substantially higher, than the total amino acid
coverage. In general, this approach allows the researcher
to determine how many peptides might reasonably be
expected to be detected.
We have also used the bursal neural network and the
Hodgkin's lymphoma model neural network to deter-
mine if proteins that are "missing" from a pathway of
interest are likely to be potentially observable. The results
are given in Table 5. As McCarthy et al. [6] reported, most
components of the programmed cell death pathway with
known orthologs in chicken were observed in the avian
bursa data set with the exception of the protein DR3. The
peptides produced by in silico tryptic digestion of DR3 (GI
118106991) were used as input to our neural network for
this data set. As shown in Table 5, none of the peptides for
this protein were predicted to be observable. In contrast,
for proteins that were observed, the average number of
observable peptides was 5. For the Hodgkin's lymphoma
model dataset, there were five proteins that we expected to
observe because we have observed them using other
methods in other experiments [15,16] but we did not see
them in this experiment (also shown in Table 5). The
results in Table 5 show that none of the tryptic peptides
for these proteins is predicted to be observable under the
given experimental conditions while a set of proteins of
similar size that were observed were predicted to be
observable. Although these results cannot be used to dem-
onstrate conclusively that a protein does or does not exist
in a data set, they can be used as one piece of evidence to
confirm or refute a hypothesis about the presence of a pro-
tein under certain conditions and to plan further wet lab
experiments.
Conclusion
We present a procedure for constructing a classifier to pre-
dict which tryptic peptides in a protein are likely to be
detectable by mass spectrometry for a specific set of exper-
imental and instrumental conditions. We demonstrate
that it is possible to construct a classifier with accuracy
comparable to those previously reported based on the
accumulation of large training sets from multiple experi-
ments. We also show that a classifier constructed based on
one dataset does not perform at an acceptable level when
predicting observability for another dataset and thus it is
necessary to construct classifiers that are specific for one
set of experimental conditions. The resulting classifier
provides researchers with a tool that can provide informa-
tion about peptide coverage of proteins in terms of which
proteins are likely to be detectable. It can also be used as
one line of evidence in a systems analysis to evaluate alter-
native hypotheses concerning proteins that were not
observed but that were expected. If the "missing" protein
generates many predicted detectable peptides but none
were observed, then this provides additional probabilistic
evidence of absence of the protein – a very difficult
hypothesis to demonstrate conclusively. The classifier
allows researchers to distinguish between proteins that are
not likely to be detected with the methodology versus pro-
teins that were not expressed in the biological system.
Only by making this distinction is it possible to accurately
interpret proteomics results and improve biological mod-
eling.
Table 4: Accuracy by class for neural networks generated using one dataset as the training set and the other dataset for test data.
Class True positive rate False positive rate Precision Recall ROC Area
Avian Bursal Dataset training set, Hodgkins Lymphoma test set
Not observed 0.71 0.46 0.61 0.71 0.70
Observed 0.54 0.29 0.66 0.54 0.70
Hodgkin's Lymphoma Model Dataset training set, Avian Bursa test set
Not observed 0.81 0.41 0.81 0.73 0.73
Observed 0.59 0.19 0.59 0.66 0.73BMC Bioinformatics 2007, 8(Suppl 7):S23 http://www.biomedcentral.com/1471-2105/8/S7/S23
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Methods
Biological samples
Methods used to collect the biological samples, analyze
the samples using mass spectrometry, and identify pro-
teins are described in detail in[5] and [6]. All samples
were analyzed by MudPIT using an LCQ Deca XP Plus IT
mass spectrometer and database search was conducted
using TurboSEQUEST (Bioworks Browser; ThermoElec-
tron).
Software
Custom Perl scripts were written to extract the accessions
of proteins and lists of peptides from Sequest output files,
to query NCBI and download the protein sequences, to
trypsin digest the proteins, to determine which peptides
had been observed in the dataset, to select the positive and
negative peptides for the data sets, and to compute the fea-
ture vectors for each peptide. The software implements the
rules for trypsin digestion described for the ExPASy Pepti-
deCutter tool [17]. WEKA Explorer Version 3.4.10, a soft-
ware package containing a collection of machine learning
algorithms for data mining available at http://
www.cs.waikato.ac.nz/ml/weka/[14] was used for feature
selection, and building and testing the classifier. The soft-
ware that generates a training set from a Sequest output
file and a detailed readme describing how to generate clas-
sifiers for a specific dataset using Weka is available for
download in the Tools section of AgBase http://
www.agbase.msstate.edu.
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